ropivacaine hydrochloride
Generic: ropivacaine hydrochloride
Labeler: somerset therapeutics, llcDrug Facts
Product Profile
Brand Name
ropivacaine hydrochloride
Generic Name
ropivacaine hydrochloride
Labeler
somerset therapeutics, llc
Dosage Form
INJECTION
Routes
Active Ingredients
ropivacaine hydrochloride 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
70069-062
Product ID
70069-062_79b226f0-c08a-4f84-bf2b-ae5c60e01d67
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207636
Listing Expiration
2026-12-31
Marketing Start
2018-06-15
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70069062
Hyphenated Format
70069-062
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ropivacaine hydrochloride (source: ndc)
Generic Name
ropivacaine hydrochloride (source: ndc)
Application Number
ANDA207636 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 10 VIAL in 1 CARTON (70069-062-10) / 20 mL in 1 VIAL (70069-062-01)
- 25 VIAL in 1 CARTON (70069-062-25) / 20 mL in 1 VIAL (70069-062-01)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["EPIDURAL", "INFILTRATION", "PERINEURAL"], "spl_id": "79b226f0-c08a-4f84-bf2b-ae5c60e01d67", "openfda": {"upc": ["0370069062104", "0370069062258", "0370069064252", "0370069061251", "0370069064016", "0370069063255", "0370069067017", "0370069066102", "0370069067109", "0370069063019", "0370069061015", "0370069065259", "0370069062012", "0370069064108", "0370069066256", "0370069067253", "0370069061107", "0370069066010", "0370069065013"], "unii": ["V910P86109"], "rxcui": ["905189", "1734084", "1734090", "1734203", "1734207", "1734475", "1734483"], "spl_set_id": ["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (70069-062-10) / 20 mL in 1 VIAL (70069-062-01)", "package_ndc": "70069-062-10", "marketing_start_date": "20220302"}, {"sample": false, "description": "25 VIAL in 1 CARTON (70069-062-25) / 20 mL in 1 VIAL (70069-062-01)", "package_ndc": "70069-062-25", "marketing_start_date": "20180615"}], "brand_name": "Ropivacaine Hydrochloride", "product_id": "70069-062_79b226f0-c08a-4f84-bf2b-ae5c60e01d67", "dosage_form": "INJECTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Local Anesthesia [PE]"], "product_ndc": "70069-062", "generic_name": "Ropivacaine Hydrochloride", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ropivacaine Hydrochloride", "active_ingredients": [{"name": "ROPIVACAINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA207636", "marketing_category": "ANDA", "marketing_start_date": "20180615", "listing_expiration_date": "20261231"}